{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T06:54:04Z","timestamp":1785048844889,"version":"3.55.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T00:00:00Z","timestamp":1447459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s10147-015-0920-6","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T08:00:17Z","timestamp":1447488017000},"page":"619-625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Tumor hypoxia: a new PET imaging biomarker in clinical oncology"],"prefix":"10.1007","volume":"21","author":[{"given":"Nagara","family":"Tamaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,14]]},"reference":[{"key":"920_CR1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0360-3016(84)90301-8","volume":"10","author":"JE Moulder","year":"1984","unstructured":"Moulder JE, Rockwell S (1984) Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 10:695\u2013712","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"920_CR2","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrc2540","volume":"8","author":"JA Bertout","year":"2008","unstructured":"Bertout JA, Patel SA, Simon MC (2008) The impact of O2 availability on human cancer. Nat Rev Cancer 8:967\u2013975. doi: 10.1038\/nrc2540","journal-title":"Nat Rev Cancer"},{"key":"920_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/1040-8428(94)00142-G","volume":"20","author":"BA Teicher","year":"1995","unstructured":"Teicher BA (1995) Angiogenesis and cancer metastases: therapeutic approaches. Crit Rev Oncol Hematol 20:9\u201339","journal-title":"Crit Rev Oncol Hematol"},{"key":"920_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/bjc.2014.610","volume":"112","author":"IN Fleming","year":"2015","unstructured":"Fleming IN, Manavaki R, Blower PJ, West C, Williams KJ, Harris AL et al (2015) Imaging tumour hypoxia with positron emission tomography. Br J Cancer 112:238\u2013250. doi: 10.1038\/bjc.2014.610","journal-title":"Br J Cancer"},{"key":"920_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1152\/physiol.00001.2004","volume":"19","author":"GL Semenza","year":"2004","unstructured":"Semenza GL (2004) Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology 19:176\u2013182. doi: 10.1152\/physiol.00001.2004","journal-title":"Physiology"},{"key":"920_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cell.2007.04.019","volume":"129","author":"B Keith","year":"2007","unstructured":"Keith B, Simon MC (2007) Hypoxia-inducible factors, stem cells, and cancer. Cell 129:465\u2013472. doi: 10.1016\/j.cell.2007.04.019","journal-title":"Cell"},{"key":"920_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1582-4934.2009.00944.x","volume":"14","author":"AM Jubb","year":"2010","unstructured":"Jubb AM, Buffa FM, Harris AL (2010) Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis. J Cell Mol Med 14:18\u201329. doi: 10.1111\/j.1582-4934.2009.00944.x","journal-title":"J Cell Mol Med"},{"issue":"Suppl 5","key":"920_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1634\/theoncologist.9-90005-31","volume":"9","author":"L Harrison","year":"2004","unstructured":"Harrison L, Blackwell K (2004) Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 9(Suppl 5):31\u201340. doi: 10.1634\/theoncologist.9-90005-31","journal-title":"Oncologist"},{"key":"920_CR9","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V82.7.2031.2031","volume":"82","author":"MG Cipolleschi","year":"1993","unstructured":"Cipolleschi MG, Dello Sbarba P, Olivotto M (1993) The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 82:2031\u20132037","journal-title":"Blood"},{"key":"920_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrc1592","volume":"5","author":"BJ Huntly","year":"2005","unstructured":"Huntly BJ, Gilliland DG (2005) Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer 5:311\u2013321. doi: 10.1038\/nrc1592","journal-title":"Nat Rev Cancer"},{"key":"920_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105\u2013111. doi: 10.1038\/35102167","journal-title":"Nature"},{"key":"920_CR12","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2014.9.FOCUS14494","volume":"37","author":"SJ Sundar","year":"2014","unstructured":"Sundar SJ, Hsieh JK, Manjila S, Lathia JD, Sloan A (2014) The role of cancer stem cells in glioblastoma. Neurosurg Focus 37:E6. doi: 10.3171\/2014.9.FOCUS14494","journal-title":"Neurosurg Focus"},{"key":"920_CR13","doi-asserted-by":"publisher","first-page":"E5429","DOI":"10.1073\/pnas.1421438111","volume":"111","author":"D Samanta","year":"2014","unstructured":"Samanta D, Gilkes DM, Chaturvedi P, Xiang L, Semenza GL (2014) Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc Natl Acad Sci USA 111:E5429\u2013E5438. doi: 10.1073\/pnas.1421438111","journal-title":"Proc Natl Acad Sci USA"},{"key":"920_CR14","first-page":"4509","volume":"56","author":"M Hockel","year":"1996","unstructured":"Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509\u20134515","journal-title":"Cancer Res"},{"key":"920_CR15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0959-8049(97)10172-1","volume":"34","author":"E Lartigau","year":"1998","unstructured":"Lartigau E, Lusinchi A, Weeger P, Wibault P, Luboinski B, Eschwege F et al (1998) Variations in tumour oxygen tension (pO2) during accelerated radiotherapy of head and neck carcinoma. Eur J Cancer 34:856\u2013861","journal-title":"Eur J Cancer"},{"key":"920_CR16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0360-3016(99)00115-7","volume":"44","author":"P Stadler","year":"1999","unstructured":"Stadler P, Becker A, Feldmann HJ, Hansgen G, Dunst J, Wurschmidt F et al (1999) Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 44:749\u2013754","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"920_CR17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0360-3016(02)04474-7","volume":"55","author":"CM Doll","year":"2003","unstructured":"Doll CM, Milosevic M, Pintilie M, Hill RP, Fyles AW (2003) Estimating hypoxic status in human tumors: a simulation using Eppendorf oxygen probe data in cervical cancer patients. Int J Radiat Oncol Biol Phys 55:1239\u20131246","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"920_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1053\/SRAO0060037","volume":"6","author":"JA Raleigh","year":"1996","unstructured":"Raleigh JA, Dewhirst MW, Thrall DE (1996) Measuring tumor hypoxia. Semin Radiat Oncol 6:37\u201345. doi: 10.1053\/SRAO0060037","journal-title":"Semin Radiat Oncol"},{"key":"920_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1259\/bjr\/82292521","volume":"842","author":"I Mendichovszky","year":"2011","unstructured":"Mendichovszky I, Jackson A (2011) Imaging hypoxia in gliomas. Br J Radiol 842:145\u2013158. doi: 10.1259\/bjr\/82292521","journal-title":"Br J Radiol"},{"key":"920_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MNM.0b013e32834eacb7","volume":"33","author":"K Chia","year":"2012","unstructured":"Chia K, Fleming IN, Blower PJ (2012) Hypoxia imaging with PET: which tracers and why? Nucl Med Commun 33:217\u2013222. doi: 10.1097\/MNM.0b013e32834eacb7","journal-title":"Nucl Med Commun"},{"key":"920_CR21","unstructured":"Piert M (2009) Hypoxia imaging. In: Wahl RL (ed) Principles and practice of PET and PET\/CT. 2nd ed: Lippincott Williams & Wilkins, Philadelphia, pp 464\u2013471"},{"key":"920_CR22","first-page":"1557","volume":"43","author":"JS Lewis","year":"2002","unstructured":"Lewis JS, Herrero P, Sharp TL, Engelbach JA, Fujibayashi Y, Laforest R et al (2002) Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone). J Nucl Med 43:1557\u20131569","journal-title":"J Nucl Med"},{"key":"920_CR23","first-page":"655","volume":"42","author":"JS Lewis","year":"2001","unstructured":"Lewis JS, Sharp TL, Laforest R, Fujibayashi Y, Welch MJ (2001) Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. J Nucl Med 42:655\u2013661","journal-title":"J Nucl Med"},{"key":"920_CR24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0360-3016(02)04477-2","volume":"55","author":"F Dehdashti","year":"2003","unstructured":"Dehdashti F, Grigsby PW, Mintun MA, Lewis JS, Siegel BA, Welch MJ (2003) Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report. Int J Radiat Oncol Biol Phys 55:1233\u20131238","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"920_CR25","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.ijrobp.2004.12.057","volume":"61","author":"JA O\u2019Donoghue","year":"2005","unstructured":"O\u2019Donoghue JA, Zanzonico P, Pugachev A, Wen B, Smith-Jones P, Cai S et al (2005) Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models. Int J Radiat Oncol Biol Phys 61:1493\u20131502. doi: 10.1016\/j.ijrobp.2004.12.057","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"920_CR26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0883-2889(86)90079-1","volume":"37","author":"PA Jerabek","year":"1986","unstructured":"Jerabek PA, Patrick TB, Kilbourn MR, Dischino DD, Welch MJ (1986) Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue. Int J Radiat Appl Instrum Part A, Appl Radiat Isot 37:599\u2013605","journal-title":"Int J Radiat Appl Instrum Part A, Appl Radiat Isot"},{"key":"920_CR27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4615-3768-7_11","volume-title":"NATO advanced research workshop on selective activation of drugs by redox processes","author":"RA McClelland","year":"1990","unstructured":"McClelland RA (1990) Molecualr interactions and biological effects of the products of reduction of nitroimidazoles. In: Adams GE, Breccia A, Fiedlen EN (eds) NATO advanced research workshop on selective activation of drugs by redox processes. New York Plenum Press, Plattsburgh, pp 125\u2013136"},{"key":"920_CR28","first-page":"343","volume":"30","author":"JR Grierson","year":"1989","unstructured":"Grierson JR, Link JM, Mathis CA, Rasey JS, Krohn KA (1989) A radiosynthesis of fluorine-18 fluoromisonidazole. J Nucl Med 30:343\u2013350","journal-title":"J Nucl Med"},{"key":"920_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s002590050365","volume":"26","author":"M Piert","year":"1999","unstructured":"Piert M, Machulla H, Becker G, Stahlschmidt A, Patt M, Aldinger P et al (1999) Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia. Eur J Nucl Med 26:95\u2013109","journal-title":"Eur J Nucl Med"},{"key":"920_CR30","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s00259-008-0772-7","volume":"35","author":"EG Troost","year":"2008","unstructured":"Troost EG, Laverman P, Philippens ME, Lok J, van der Kogel AJ, Oyen WJ et al (2008) Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts. Eur J Nucl Med Mol Imaging 35:1803\u20131811. doi: 10.1007\/s00259-008-0772-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"920_CR31","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1186\/1471-2407-14-692","volume":"14","author":"CN Fatema","year":"2014","unstructured":"Fatema CN, Zhao S, Zhao Y, Yu W, Nishijima K, Yasuda K et al (2014) Dual tracer evaluation of dynamic changes in intratumoral hypoxic and proliferative states after radiotherapy of human head and neck cancer xenografts using radiolabeled FMISO and FLT. BMC Cancer 14:692. doi: 10.1186\/1471-2407-14-692","journal-title":"BMC Cancer"},{"key":"920_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1088\/0031-9155\/59\/2\/347","volume":"59","author":"X Cheng","year":"2014","unstructured":"Cheng X, Bayer C, Maftei CA, Astner ST, Vaupel P, Ziegler SI et al (2014) Preclinical evaluation of parametric image reconstruction of [18F]FMISO PET: correlation with ex vivo immunohistochemistry. Phys Med Biol 59:347\u2013362. doi: 10.1088\/0031-9155\/59\/2\/347","journal-title":"Phys Med Biol"},{"key":"920_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3892\/ijo.2013.1781","volume":"42","author":"T Hatano","year":"2013","unstructured":"Hatano T, Zhao S, Zhao Y, Nishijima K, Kuno N, Hanzawa H et al (2013) Biological characteristics of intratumoral [F-18]fluoromisonidazole distribution in a rodent model of glioma. Int J Oncol 42:823\u2013830. doi: 10.3892\/ijo.2013.1781","journal-title":"Int J Oncol"},{"key":"920_CR34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2967\/jnumed.110.081372","volume":"52","author":"C Oehler","year":"2011","unstructured":"Oehler C, O\u2019Donoghue JA, Russell J, Zanzonico P, Lorenzen S, Ling CC et al (2011) 18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors. J Nucl Med 52:437\u2013444. doi: 10.2967\/jnumed.110.081372","journal-title":"J Nucl Med"},{"key":"920_CR35","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3892\/ijo.2012.1624","volume":"41","author":"M Murakami","year":"2012","unstructured":"Murakami M, Zhao S, Zhao Y, Chowdhury NF, Yu W, Nishijima K et al (2012) Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and 18F-fluoromisonidazole hypoxia imaging in renal cell carcinoma. Int J Oncol 41:1593\u20131600. doi: 10.3892\/ijo.2012.1624","journal-title":"Int J Oncol"},{"key":"920_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","volume":"77","author":"M Nordsmark","year":"2005","unstructured":"Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P et al (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77:18\u201324. doi: 10.1016\/j.radonc.2005.06.038","journal-title":"Radiother Oncol"},{"key":"920_CR37","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1158\/1078-0432.CCR-05-1773","volume":"12","author":"JG Rajendran","year":"2006","unstructured":"Rajendran JG, Schwartz DL, O\u2019Sullivan J, Peterson LM, Ng P, Scharnhorst J et al (2006) Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res 12:5435\u20135441. doi: 10.1158\/1078-0432.CCR-05-1773","journal-title":"Clin Cancer Res"},{"key":"920_CR38","first-page":"253","volume":"46","author":"SM Eschmann","year":"2005","unstructured":"Eschmann SM, Paulsen F, Reimold M, Dittmann H, Welz S, Reischl G et al (2005) Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46:253\u2013260","journal-title":"J Nucl Med"},{"key":"920_CR39","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s12149-011-0508-9","volume":"25","author":"M Kikuchi","year":"2011","unstructured":"Kikuchi M, Yamane T, Shinohara S, Fujiwara K, Hori SY, Tona Y et al (2011) 18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma. Ann Nucl Med 25:625\u2013633. doi: 10.1007\/s12149-011-0508-9","journal-title":"Ann Nucl Med"},{"key":"920_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1200\/JCO.2005.01.072","volume":"23","author":"D Rischin","year":"2005","unstructured":"Rischin D, Peters L, Fisher R, Macann A, Denham J, Poulsen M et al (2005) Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). J Clin Oncol 23:79\u201387. doi: 10.1200\/JCO.2005.01.072","journal-title":"J Clin Oncol"},{"key":"920_CR41","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721\u2013732. doi: 10.1038\/nrc1187","journal-title":"Nat Rev Cancer"},{"key":"920_CR42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ncomms1786","volume":"3","author":"H Harada","year":"2012","unstructured":"Harada H, Inoue M, Itasaka S, Hirota K, Morinibu A, Shinomiya K et al (2012) Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels. Nat Commun 3:783. doi: 10.1038\/ncomms1786","journal-title":"Nat Commun"},{"key":"920_CR43","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.2967\/jnumed.112.114355","volume":"54","author":"J Sato","year":"2013","unstructured":"Sato J, Kitagawa Y, Yamazaki Y, Hata H, Okamoto S, Shiga T et al (2013) 18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1alpha expression in oral squamous cell carcinoma. J Nucl Med 54:1060\u20131065. doi: 10.2967\/jnumed.112.114355","journal-title":"J Nucl Med"},{"key":"920_CR44","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.ijrobp.2007.09.050","volume":"70","author":"Z Lin","year":"2008","unstructured":"Lin Z, Mechalakos J, Nehmeh S, Schoder H, Lee N, Humm J et al (2008) The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys 70:1219\u20131228. doi: 10.1016\/j.ijrobp.2007.09.050","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"920_CR45","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2967\/jnumed.109.062638","volume":"50","author":"P Dirix","year":"2009","unstructured":"Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, Nuyts S (2009) Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med 50:1020\u20131027. doi: 10.2967\/jnumed.109.062638","journal-title":"J Nucl Med"},{"key":"920_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ijrobp.2007.06.039","volume":"70","author":"NY Lee","year":"2008","unstructured":"Lee NY, Mechalakos JG, Nehmeh S, Lin Z, Squire OD, Cai S et al (2008) Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys 70:2\u201313. doi: 10.1016\/j.ijrobp.2007.06.039","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl. 5","key":"920_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1634\/theoncologist.9-90005-4","volume":"9","author":"P Vaupel","year":"2004","unstructured":"Vaupel P, Harrison L (2004) Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 9(Suppl. 5):4\u20139. doi: 10.1634\/theoncologist.9-90005-4","journal-title":"Oncologist"},{"key":"920_CR48","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1088\/0031-9155\/57\/6\/1675","volume":"57","author":"D Monnich","year":"2012","unstructured":"Monnich D, Troost EG, Kaanders JH, Oyen WJ, Alber M, Thorwarth D (2012) Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging. Phys Med Biol 57:1675\u20131684. doi: 10.1088\/0031-9155\/57\/6\/1675","journal-title":"Phys Med Biol"},{"key":"920_CR49","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ijrobp.2007.08.036","volume":"70","author":"SA Nehmeh","year":"2008","unstructured":"Nehmeh SA, Lee NY, Schroder H, Squire O, Zanzonico PB, Erdi YE et al (2008) Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. Int J Radiat Oncol Biol Phys 70:235\u2013242. doi: 10.1016\/j.ijrobp.2007.08.036","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"920_CR50","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s00066-004-1229-y","volume":"180","author":"B Gagel","year":"2004","unstructured":"Gagel B, Reinartz P, Dimartino E, Zimny M, Pinkawa M, Maneschi P et al (2004) pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2\u2032-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia. Strahlenther Onkol 180:616\u2013622. doi: 10.1007\/s00066-004-1229-y","journal-title":"Strahlenther Onkol"},{"key":"920_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2967\/jnumed.112.109330","volume":"54","author":"S Okamoto","year":"2013","unstructured":"Okamoto S, Shiga T, Yasuda K, Ito YM, Magota K, Kasai K et al (2013) High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer. J Nucl Med 54:201\u2013207. doi: 10.2967\/jnumed.112.109330","journal-title":"J Nucl Med"},{"key":"920_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.radonc.2006.07.033","volume":"80","author":"D Thorwarth","year":"2006","unstructured":"Thorwarth D, Eschmann SM, Holzner F, Paulsen F, Alber M (2006) Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients. Radiother Oncol 80:151\u2013156. doi: 10.1016\/j.radonc.2006.07.033","journal-title":"Radiother Oncol"},{"key":"920_CR53","first-page":"68","volume":"28","author":"Z Grunbaum","year":"1987","unstructured":"Grunbaum Z, Freauff SJ, Krohn KA, Wilbur DS, Magee S, Rasey JS (1987) Synthesis and characterization of congeners of misonidazole for imaging hypoxia. J Nucl Med 28:68\u201375","journal-title":"J Nucl Med"},{"key":"920_CR54","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1109\/Tns.2011.2146790","volume":"58","author":"Y Morimoto","year":"2011","unstructured":"Morimoto Y, Ueno Y, Takeuchi W, Kojima S, Matsuzaki K, Ishitsu T et al (2011) Development of a 3D brain PET scanner using CdTe semiconductor detectors and its first clinical application. IEEE Trans Nucl Sci 58:2181\u20132189. doi: 10.1109\/Tns.2011.2146790","journal-title":"IEEE Trans Nucl Sci"},{"key":"920_CR55","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2967\/jnumed.108.054833","volume":"50","author":"T Shiga","year":"2009","unstructured":"Shiga T, Morimoto Y, Kubo N, Katoh N, Katoh C, Takeuchi W et al (2009) A new PET scanner with semiconductor detectors enables better identification of intratumoral inhomogeneity. J Nucl Med 50:148\u2013155. doi: 10.2967\/jnumed.108.054833","journal-title":"J Nucl Med"},{"key":"920_CR56","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijrobp.2012.03.029","volume":"85","author":"K Yasuda","year":"2013","unstructured":"Yasuda K, Onimaru R, Okamoto S, Shiga T, Katoh N, Tsuchiya K et al (2013) [18F]fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 85:142\u2013147. doi: 10.1016\/j.ijrobp.2012.03.029","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"920_CR57","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00259-014-2810-y","volume":"41","author":"J Sato","year":"2014","unstructured":"Sato J, Kitagawa Y, Yamazaki Y, Hata H, Asaka T, Miyakoshi M et al (2014) Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma. Eur J Nucl Med Mol Imaging 41:2031\u20132041. doi: 10.1007\/s00259-014-2810-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"920_CR58","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/jrr\/rrt033","volume":"54","author":"I Tachibana","year":"2013","unstructured":"Tachibana I, Nishimura Y, Shibata T, Kanamori S, Nakamatsu K, Koike R et al (2013) A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET\/CT) before and during radiation therapy. J Radiat Res 54:1078\u20131084. doi: 10.1093\/jrr\/rrt033","journal-title":"J Radiat Res"},{"key":"920_CR59","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1007\/s00259-014-2730-x","volume":"41","author":"S Servagi-Vernat","year":"2014","unstructured":"Servagi-Vernat S, Differding S, Hanin FX, Labar D, Bol A, Lee JA et al (2014) A prospective clinical study of (1)(8)F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy. Eur J Nucl Med Mol Imaging 41:1544\u20131552. doi: 10.1007\/s00259-014-2730-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"920_CR60","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s00259-011-2037-0","volume":"39","author":"K Hirata","year":"2012","unstructured":"Hirata K, Terasaka S, Shiga T, Hattori N, Magota K, Kobayashi H et al (2012) (18)F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas. Eur J Nucl Med Mol Imaging 39:760\u2013770. doi: 10.1007\/s00259-011-2037-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"920_CR61","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/MNM.0b013e3283529984","volume":"33","author":"Y Yamamoto","year":"2012","unstructured":"Yamamoto Y, Maeda Y, Kawai N, Kudomi N, Aga F, Ono Y et al (2012) Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas. Nucl Med Commun 33:621\u2013625. doi: 10.1097\/MNM.0b013e3283529984","journal-title":"Nucl Med Commun"},{"key":"920_CR62","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00259-010-1645-4","volume":"38","author":"N Kawai","year":"2011","unstructured":"Kawai N, Maeda Y, Kudomi N, Miyake K, Okada M, Yamamoto Y et al (2011) Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma. Eur J Nucl Med Mol Imaging 38:441\u2013450. doi: 10.1007\/s00259-010-1645-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"920_CR63","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1158\/0008-5472.CAN-08-3884","volume":"69","author":"MD Szeto","year":"2009","unstructured":"Szeto MD, Chakraborty G, Hadley J, Rockne R, Muzi M, Alvord EC Jr et al (2009) Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas. Cancer Res 69:4502\u20134509. doi: 10.1158\/0008-5472.CAN-08-3884","journal-title":"Cancer Res"},{"key":"920_CR64","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1158\/1078-0432.CCR-07-4995","volume":"14","author":"AM Spence","year":"2008","unstructured":"Spence AM, Muzi M, Swanson KR, O\u2019Sullivan F, Rockhill JK, Rajendran JG et al (2008) Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res 14:2623\u20132630. doi: 10.1158\/1078-0432.CCR-07-4995","journal-title":"Clin Cancer Res"},{"key":"920_CR65","unstructured":"Cher LM, Murone C, Lawrentschuk N, Ramdave S, Papenfuss A, Hannah A et al (2006) Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J Nucl Med 47:410\u2013418"},{"key":"920_CR66","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1007\/s00259-014-2776-9","volume":"41","author":"N Kawai","year":"2014","unstructured":"Kawai N, Lin W, Cao WD, Ogawa D, Miyake K, Haba R et al (2014) Correlation between (1)(8)F-fluoromisonidazole PET and expression of HIF-1alpha and VEGF in newly diagnosed and recurrent malignant gliomas. Eur J Nucl Med Mol Imaging 41:1870\u20131878. doi: 10.1007\/s00259-014-2776-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"920_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2407-6-51","volume":"6","author":"B Gagel","year":"2006","unstructured":"Gagel B, Reinartz P, Demirel C, Kaiser HJ, Zimny M, Piroth M et al (2006) [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-\/radiotherapy of non-small-cell lung cancer: a feasibility study. BMC Cancer 6:51. doi: 10.1186\/1471-2407-6-51","journal-title":"BMC Cancer"},{"key":"920_CR68","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3816\/CLC.2010.n.042","volume":"11","author":"L Li","year":"2010","unstructured":"Li L, Hu M, Zhu H, Zhao W, Yang G, Yu J (2010) Comparison of 18F-Fluoroerythronitroimidazole and 18F-fluorodeoxyglucose positron emission tomography and prognostic value in locally advanced non-small-cell lung cancer. Clin Lung Cancer 11:335\u2013340. doi: 10.3816\/CLC.2010.n.042","journal-title":"Clin Lung Cancer"},{"key":"920_CR69","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2967\/jnumed.112.118083","volume":"54","author":"S Thureau","year":"2013","unstructured":"Thureau S, Chaumet-Riffaud P, Modzelewski R, Fernandez P, Tessonnier L, Vervueren L et al (2013) Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3\u2032-deoxy-3\u2032-18F-fluorothymidine PET images in lung cancer. J Nucl Med 54:1543\u20131550. doi: 10.2967\/jnumed.112.118083","journal-title":"J Nucl Med"},{"key":"920_CR70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.radonc.2010.10.011","volume":"98","author":"P Vera","year":"2011","unstructured":"Vera P, Bohn P, Edet-Sanson A, Salles A, Hapdey S, Gardin I et al (2011) Simultaneous positron emission tomography (PET) assessment of metabolism with (1)(8)F-fluoro-2-deoxy-d-glucose (FDG), proliferation with (1)(8)F-fluoro-thymidine (FLT), and hypoxia with (1)(8)fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study. Radiother Oncol 98:109\u2013116. doi: 10.1016\/j.radonc.2010.10.011","journal-title":"Radiother Oncol"},{"key":"920_CR71","first-page":"1921","volume":"47","author":"MH Cherk","year":"2006","unstructured":"Cherk MH, Foo SS, Poon AM, Knight SR, Murone C, Papenfuss AT et al (2006) Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET. J Nucl Med 47:1921\u20131926","journal-title":"J Nucl Med"},{"key":"920_CR72","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0360-3016(95)00170-4","volume":"33","author":"WJ Koh","year":"1995","unstructured":"Koh WJ, Bergman KS, Rasey JS, Peterson LM, Evans ML, Graham MM et al (1995) Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys 33:391\u2013398. doi: 10.1016\/0360-3016(95)00170-4","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"920_CR73","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2967\/jnumed.112.111963","volume":"54","author":"J Cheng","year":"2013","unstructured":"Cheng J, Lei L, Xu J, Sun Y, Zhang Y, Wang X et al (2013) 18F-fluoromisonidazole PET\/CT: a potential tool for predicting primary endocrine therapy resistance in breast cancer. J Nucl Med 54:333\u2013340. doi: 10.2967\/jnumed.112.111963","journal-title":"J Nucl Med"},{"key":"920_CR74","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1464-410X.2005.05681.x","volume":"96","author":"N Lawrentschuk","year":"2005","unstructured":"Lawrentschuk N, Poon AM, Foo SS, Putra LG, Murone C, Davis ID et al (2005) Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography. BJU Int 96:540\u2013546. doi: 10.1111\/j.1464-410X.2005.05681.x","journal-title":"BJU Int"},{"key":"920_CR75","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijrobp.2008.10.049","volume":"75","author":"N Lee","year":"2009","unstructured":"Lee N, Nehmeh S, Schoder H, Fury M, Chan K, Ling CC et al (2009) Prospective trial incorporating pre-\/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 75:101\u2013108. doi: 10.1016\/j.ijrobp.2008.10.049","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"920_CR76","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/15330346070060S410","volume":"6","author":"TF DeLaney","year":"2007","unstructured":"DeLaney TF (2007) Clinical proton radiation therapy research at the Francis H. Burr Proton Therapy Center. Technol Cancer Res Treat 6:61\u201366","journal-title":"Technol Cancer Res Treat"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-015-0920-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-015-0920-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-015-0920-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T10:57:29Z","timestamp":1599821849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-015-0920-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,14]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["920"],"URL":"https:\/\/doi.org\/10.1007\/s10147-015-0920-6","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,14]]}}}